急性髓细胞白血病治疗策略的大剂量疗法：如何选择？ - Suppr | 超能文献

High dose therapy for acute myelocytic leukemia treatment strategy: what is the choice?

作者信息

Gorin N C, Dicke K, Löwenberg B

机构信息

Department of Hematology, Hôpital Saint-Antoine, Paris, France.

出版信息

Ann Oncol. 1993;4 Suppl 1:59-80. doi: 10.1093/annonc/4.suppl_1.s59.

DOI:10.1093/annonc/4.suppl_1.s59

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

High dose therapy for acute myelocytic leukemia treatment strategy: what is the choice?急性髓细胞白血病治疗策略的大剂量疗法：如何选择？

Ann Oncol. 1993;4 Suppl 1:59-80. doi: 10.1093/annonc/4.suppl_1.s59.

2

Strategies for acute myelogenous leukemia.急性髓系白血病的治疗策略

Bone Marrow Transplant. 1991;7 Suppl 2:58.

3

Autologous bone marrow transplantation in first remission AML--its relative value.急性髓系白血病首次缓解期的自体骨髓移植——其相对价值。

Bone Marrow Transplant. 1990 Jul;6 Suppl 1:52-4.

4

How do allogeneic bone marrow transplants cure leukaemia? The role of graft versus host disease.

Bone Marrow Transplant. 1991;7 Suppl 2:9-10.

5

Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT Group.异基因与自体骨髓移植对比化疗治疗首次完全缓解的急性髓系白血病（BGM 84和BGMT 87研究）。BGMT研究组

Bone Marrow Transplant. 1991;7 Suppl 2:36.

6

Treatment of acute myelogenous leukaemia.急性髓性白血病的治疗。

J Intern Med Suppl. 1997;740:17-22.

7

Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group.首次缓解期急性髓性白血病（AML）中异基因与自体骨髓移植（BMT）对比强化巩固治疗。一项欧洲癌症研究与治疗组织（EORTC）-意大利多中心白血病研究组（GIMEMA）的III期试验（AML8 A）。EORTC白血病协作组和GIMEMA组

Leukemia. 1992;6 Suppl 2:114-5.

8

Allogeneic and autologous bone marrow transplantation for patients with acute non-lymphoblastic leukemia in first complete remission. The Genoa experience on 119 patients.首次完全缓解的急性非淋巴细胞白血病患者的异基因和自体骨髓移植。热那亚对119例患者的经验。

Bone Marrow Transplant. 1990 Jul;6 Suppl 1:55.

9

Cure of acute myelocytic leukemia in adults: a reality.成人急性髓细胞白血病的治愈：成为现实。

Leukemia. 1990 May;4(5):313-5.

10

Allogeneic marrow transplantation for acute non-lymphoblastic leukemia: first remission versus after first relapse.

Bone Marrow Transplant. 1989 Jan;4 Suppl 1:244-6.

引用本文的文献

1

Cost-effective use of autologous bone marrow transplantation: few answers, many questions, and suggestions for future assessments.自体骨髓移植的成本效益使用：答案寥寥，问题众多，以及对未来评估的建议。

Pharmacoeconomics. 1994 Aug;6(2):114-26. doi: 10.2165/00019053-199406020-00004.

2

Infections in neutropenic patients. II: Management.中性粒细胞减少患者的感染。II：管理。

Med Oncol. 1996 Mar;13(1):63-9. doi: 10.1007/BF02988841.